WallStreetZenWallStreetZen

NASDAQ: SIBN
Si Bone Inc Stock

Overview
ForecastEarningsDividendOwnership
$15.30+0.07 (+0.46%)
Updated Apr 18, 2024
SIBN Price
$15.30
Fair Value Price
N/A
Market Cap
$628.29M
52 Week Low
$14.84
52 Week High
$29.51
P/E
-13.54x
P/B
3.71x
P/S
5.81x
PEG
N/A
Dividend Yield
N/A
Revenue
$138.89M
Earnings
-$43.34M
Gross Margin
78.8%
Operating Margin
-28.71%
Profit Margin
-31.2%
Debt to Equity
0.36
Operating Cash Flow
-$19M
Beta
1.1
Next Earnings
May 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

SIBN Overview

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Zen Score

–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SIBN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SIBN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SIBN is poor value based on its book value relative to its share price (3.71x), compared to the US Medical Devices industry average (3.63x)
P/B vs Industry Valuation
SIBN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SIBN due diligence checks available for Premium users.

Be the first to know about important SIBN news, forecast changes, insider trades & much more!

SIBN News

Valuation

SIBN fair value

Fair Value of SIBN stock based on Discounted Cash Flow (DCF)
Price
$15.30
Fair Value
-$0.04
Undervalued by
36,780.62%
SIBN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SIBN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-13.54x
Industry
28.61x
Market
41.33x

SIBN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.71x
Industry
3.63x
SIBN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SIBN's financial health

Profit margin

Revenue
$38.9M
Net Income
-$11.0M
Profit Margin
-28.3%
SIBN's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
SIBN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$230.4M
Liabilities
$61.1M
Debt to equity
0.36
SIBN's short-term assets ($211.39M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SIBN's short-term assets ($211.39M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SIBN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SIBN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.3M
Investing
-$18.9M
Financing
$842.0k
SIBN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SIBN vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
SIBN$628.29M+0.46%-13.54x3.71x
QTRX$601.02M+0.25%-18.36x1.73x
VREX$676.80M+0.06%15.24x1.19x
SILK$682.42M-0.23%-12.10x4.51x
KIDS$693.77M-1.47%-32.02x1.84x
View Top Medical Device Stocks

Si Bone Stock FAQ

What is Si Bone's quote symbol?

(NASDAQ: SIBN) Si Bone trades on the NASDAQ under the ticker symbol SIBN. Si Bone stock quotes can also be displayed as NASDAQ: SIBN.

If you're new to stock investing, here's how to buy Si Bone stock.

What is the 52 week high and low for Si Bone (NASDAQ: SIBN)?

(NASDAQ: SIBN) Si Bone's 52-week high was $29.51, and its 52-week low was $14.84. It is currently -48.15% from its 52-week high and 3.1% from its 52-week low.

How much is Si Bone stock worth today?

(NASDAQ: SIBN) Si Bone currently has 41,064,511 outstanding shares. With Si Bone stock trading at $15.30 per share, the total value of Si Bone stock (market capitalization) is $628.29M.

Si Bone stock was originally listed at a price of $20.06 in Oct 17, 2018. If you had invested in Si Bone stock at $20.06, your return over the last 5 years would have been -23.73%, for an annualized return of -5.27% (not including any dividends or dividend reinvestments).

How much is Si Bone's stock price per share?

(NASDAQ: SIBN) Si Bone stock price per share is $15.30 today (as of Apr 18, 2024).

What is Si Bone's Market Cap?

(NASDAQ: SIBN) Si Bone's market cap is $628.29M, as of Apr 20, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Si Bone's market cap is calculated by multiplying SIBN's current stock price of $15.30 by SIBN's total outstanding shares of 41,064,511.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.